Trial Profile
Comparison of Aripiprazole Augmentation vs Switching to Different Class of Antidepressants for Patients With MDD Who Are Partially/Minimally Responsive to Current Antidepressants:Randomized, Rater-blinded, Prospective Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Antidepressants
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms CASCADE
- 10 Dec 2011 New trial record